B Cell Biology Section Brings Autoimmunity, Lymphoma, and Germinal Center Biology Into Focus
Frontiers in Immunology’s B Cell Biology section is built around one of immunology’s most clinically consequential cell lineages. B cells shape antibody production, memory responses, and the germinal center reactions that can protect against infection or, when dysregulated, drive autoimmunity and malignancy. The section’s current portfolio reflects that dual role with unusual clarity: recent papers span preterm neurodevelopment, gammaherpesvirus-linked lymphomagenesis, BAFF signaling in cancer and autoimmune disease, and a renal case report tied to Waldenström macroglobulinemia.
The breadth is not accidental. B-cell biology sits at the intersection of host defense and immune pathology, which is why the section attracts work that reaches from basic mechanisms to clinically recognizable syndromes. A disorder of B-cell signaling can appear first as antibody failure, chronic inflammation, lymphoid expansion, or tissue injury. In practice, the same immune circuit that helps clear pathogens can also sustain ectopic lymphoid structures, foster malignant transformation, or amplify organ damage in autoimmune disease.
Recent content in the section makes that tension visible immediately.
Germinal Center Failure and the Biology of Viral Lymphoma
Among the most clinically direct contributions is Impaired immune surveillance exposes the germinal center as a niche for gammaherpesvirus-associated B cell lymphomagenesis. The title alone signals a central immunologic problem: when immune surveillance weakens, the germinal center can become a permissive microenvironment for virus-associated B-cell cancer. Germinal centers are designed for affinity maturation and selection, but they are also a setting in which proliferating B cells are vulnerable to oncogenic error if surveillance breaks down.
That biological logic matters at the bedside because it links infection biology with hematologic malignancy rather than treating them as separate domains. Gammaherpesviruses exploit proliferative B-cell programs, and the germinal center offers the cellular machinery needed for expansion, mutation, and selection. When surveillance fails, the same microanatomic niche that normally refines protective antibodies can become a cradle for lymphomagenesis.
BAFF as a Context-Dependent Signal in Cancer and Autoimmunity
A second paper, Context-Dependent Immunoregulation by BAFF: Reconciling Its Pro-Tumorigenic, Anti-Tumor, and Autoimmune Roles Through a Multi-Factorial Lens, reflects how B-cell survival signals resist simple classification. BAFF is not a one-directional molecule with a single clinical consequence. Its effects vary with immune context, disease stage, and the surrounding inflammatory environment.
In autoimmune disease, persistent BAFF activity can support the survival of autoreactive B cells that should have been deleted or silenced. In malignancy, the same survival pressure may help sustain abnormal B-cell clones, while in other settings BAFF-related signaling may intersect with anti-tumor immunity in more complex ways. A molecule that preserves B-cell homeostasis can therefore become part of a disease-supporting circuit when regulation is lost. The section’s framing makes clear that future interpretation of BAFF biology will have to account for tissue context rather than relying on a single mechanistic label.
Renal Disease in Waldenström Macroglobulinemia Extends the Clinical Footprint
The case report Crystalline κ-light-chain proximal tubulopathy in Waldenström macroglobulinemia with an IgA nephropathy pattern pushes B-cell biology into nephrology. Waldenström macroglobulinemia is a B-cell disorder, and the kidney can become a target when monoclonal proteins deposit or injure the proximal tubule. Crystalline light-chain tubulopathy is a striking example of how a hematologic clone can translate into structural renal damage.
The added IgA nephropathy pattern makes the presentation even more clinically layered. Renal pathology in plasma cell and B-cell disorders often reflects more than one injury pathway at once, which complicates diagnosis and widens the differential for proteinuria, hematuria, and kidney dysfunction. In a real clinical setting, this is the sort of case that requires close coordination between hematology, nephrology, and renal pathology, because the kidney lesion can reveal the hidden biology of the underlying clone.
Preterm Preschoolers and Immune Signatures Beyond the Hematologic Lens
Not every paper in the section focuses on classical B-cell pathology. The original research article on immune and body composition signatures of neurodevelopmental impairments in preterm preschoolers shows how broad the immunologic framing can become when investigators examine early-life development. Preterm birth changes immune maturation, metabolic trajectories, and neurodevelopmental risk all at once. A section devoted to B-cell biology can still be an apt home for work exploring immune signatures in this vulnerable population, because immune development is rarely isolated from growth and neurologic outcome.
The inclusion of body composition in the same analysis suggests a systems-level view of pediatric development rather than a narrow single-organ model. Immune patterning in early childhood may coincide with nutritional status, growth pattern, and developmental vulnerability, and the section’s scope accommodates that type of translational work.
An Editorial Network Built Around Mechanism and Disease Translation
The section is led by chief editor Harry W. Schroeder at the University of Alabama at Birmingham, with associate editors Mustafa Akkoyunlu of the U.S. Food and Drug Administration, Jessy J. Alexander at the University at Buffalo, and Jen Anolik at the University of Rochester. Their combined roles mirror the section itself: a mix of fundamental biology, regulatory perspective, and disease-focused immunology.
This editorial structure is relevant because B-cell biology rarely stays confined to one specialty. A mechanistic insight about germinal center selection can influence lymphoma research. A signal pathway implicated in B-cell survival can reshape autoimmunity studies. A monoclonal protein disorder can force clinicians to think across hematology and renal medicine at the same time.
The current research topics open for submission reinforce that direction, with calls centered on autoimmunity, innate immune interactions, lymphoid plasticity, and RNA-binding proteins in B-cell homeostasis and lymphomagenesis. Each topic points to the same central premise: B cells are not simply antibody factories. They are adaptive immune regulators whose misdirection can produce cancer, autoimmunity, and end-organ injury.
The most immediate limitation of the section page is also its defining feature. It is a curated research venue rather than a single clinical trial readout, so the value lies in the pattern of questions being asked, not in one numeric endpoint. The clinical relevance comes from the concentration of work around disease mechanisms that still shape diagnosis, prognosis, and therapeutic targeting across immunology, hematology, and nephrology.